CAS Stock Analysis: Cascades | TO
Packaging & Containers | TO, Canada | Market Cap: 1.747m CAD | 12M Return: 66.6% | CA1469001053 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.92M
EPS Trend: 27.7%
Qual. Beats: 1
Rev. Trend: 89.4%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cascades Inc. is a Canadian packaging and tissue products producer serving customers in Canada and the United States. Its Packaging Products and Tissue Papers segments offer fiber-based food, protective, e-commerce and retail packaging, hygiene products, and paper materials, alongside recycling, logistics and inventory-management services.
Operating in the paper and packaging materials industry, Cascades combines manufacturing and converting with recycling activities. Its products serve sectors such as food, retail and shipping, where paper-based packaging is used to protect and transport goods.
- Packaging margins move with box demand, selling prices, and recycled-fiber costs
- Tissue segment profitability depends on pricing, input costs, and competition
- Mill closures and efficiency investments shape costs, capital spending, and cash flow
| Net Income: 126.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 5.15 > 1.0 |
| NWC/Revenue: 8.81% < 20% (prev 8.82%; Δ -0.01% < -1%) |
| CFO/TA 0.10 > 3% & CFO 498.0m > Net Income 126.0m |
| Net Debt (2.15b) to EBITDA (560.0m): 3.84 < 3 |
| Current Ratio: 1.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (101.7m) vs 12m ago 0.49% < -2% |
| Gross Margin: 11.15% > 18% (prev 40.29%; Δ -29.14% > 0.5%) |
| Asset Turnover: 99.17% > 50% (prev 98.79%; Δ 0.38% > 0%) |
| Interest Coverage Ratio: 2.13 > 6 (EBIT TTM 266.0m / Interest Expense TTM 125.0m) |
| A: 0.09 (Total Current Assets 1.29b - Total Current Liabilities 874.0m) / Total Assets 4.83b |
| B: 0.22 (Retained Earnings 1.08b / Total Assets 4.83b) |
| C: 0.06 (EBIT TTM 266.0m / Avg Total Assets 4.82b) |
| D: 0.59 (Book Value of Equity 1.78b / Total Liabilities 3.01b) |
| Altman-Z'' = 2.29 = BBB |
| DSRI: 1.02 (Receivables 488.0m/477.0m, Revenue 4.78b/4.75b) |
| GMI: 3.61 (GM 40.29% / 11.15%) |
| AQI: 0.94 (AQ_t 0.18 / AQ_t-1 0.20) |
| SGI: 1.01 (Revenue 4.78b / 4.75b) |
| TATA: -0.08 (NI 126.0m - CFO 498.0m) / TA 4.83b) |
| Beneish M = -0.68 (Cap -4..+1) = D |
As of November 03, 2026, the stock is trading at CAD 17.86 with a total of 697,093 shares traded. Over the past week, the price has changed by +4.57%, over one month by -1.65%, over three months by +27.00% and over the past year by +66.60%.
Current recommended Stop Loss: 16.90 (which is 5.4% or 2 ATR below the current price).
Cascades has no consensus analysts rating.
P/E Trailing = 13.8952
P/E Forward = 8.0192
P/S = 0.3657
P/B = 0.9902
P/EG = 0.47
Revenue TTM = 4.78b CAD
EBIT TTM = 266.0m CAD
EBITDA TTM = 560.0m CAD
Long Term Debt = 1.69b CAD (from longTermDebt, last quarter)
Short Term Debt = 78.0m CAD (from shortTermDebt, last quarter)
Debt = 2.25b CAD (from shortLongTermDebtTotal, last quarter) + Leases 274.0m
Net Debt = 2.15b CAD (calculated: Debt 2.25b - CCE 96.0m)
Enterprise Value = 3.90b CAD (1.75b + Debt 2.25b - CCE 96.0m)
Interest Coverage Ratio = 2.13 (Ebit TTM 266.0m / Interest Expense TTM 125.0m)
EV/FCF = 10.93x (Enterprise Value 3.90b / FCF TTM 357.0m)
FCF Yield = 9.15% (FCF TTM 357.0m / Enterprise Value 3.90b)
FCF Margin = 7.47% (FCF TTM 357.0m / Revenue TTM 4.78b)
Net Margin = 2.64% (Net Income TTM 126.0m / Revenue TTM 4.78b)
Gross Margin = 11.15% ((Revenue TTM 4.78b - Cost of Revenue TTM 4.25b) / Revenue TTM)
Gross Margin QoQ = 10.09% (prev 9.69%)
Tobins Q-Ratio = 0.81 (Enterprise Value 3.90b / Total Assets 4.83b)
Interest Expense / Debt = 5.56% (Interest Expense 125.0m / Debt 2.25b)
Taxrate = 15.73% (28.0m / 178.0m)
NOPAT = 224.2m (EBIT 266.0m * (1 - 15.73%))
Current Ratio = 1.48 (Total Current Assets 1.29b / Total Current Liabilities 874.0m)
Debt / Equity = 1.26 (Debt 2.25b / totalStockholderEquity, last quarter 1.78b)
Debt / EBITDA = 3.84 (Net Debt 2.15b / EBITDA 560.0m)
Debt / FCF = 6.03 (Net Debt 2.15b / FCF TTM 357.0m)
Total Stockholder Equity = 1.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.61% (Net Income 126.0m / Total Assets 4.83b)
RoE = 7.24% (Net Income TTM 126.0m / Total Stockholder Equity 1.74b)
RoCE = 7.76% (EBIT 266.0m / Capital Employed (Equity 1.74b + L.T.Debt 1.69b))
RoIC = 5.70% (NOPAT 224.2m / Invested Capital 3.94b)
WACC = 5.84% (E(1.75b)/V(4.00b) * Re(7.32%) + D(2.25b)/V(4.00b) * Rd(5.56%) * (1-Tc(0.16)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.48 | Cagr: 0.42%
[DCF] Terminal Value 77.97% ; FCFF base≈257.4m ; Y1≈295.1m ; Y5≈434.3m
[DCF] Fair Price = 43.21 (EV 6.53b - Net Debt 2.15b = Equity 4.38b / Shares 101.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 27.73 | EPS CAGR: 19.00% | SUE: 2.81 | # QB: 1
Revenue Correlation: 89.38 | Revenue CAGR: 1.48% | SUE: 0.64 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.39 | Chg30d=-11.45% | Revisions=+25% | Analysts=6
EPS current Year (2026-12-31): EPS=1.24 | Chg30d=-6.74% | Revisions=-25% | GrowthEPS=+12.5% | GrowthRev=+3.6%
EPS next Year (2027-12-31): EPS=1.98 | Chg30d=+0.19% | Revisions=-25% | GrowthEPS=+60.3% | GrowthRev=+7.8%
[Analyst] Revisions Ratio: -17% (up=1, down=2)